» Articles » PMID: 18712568

Prognostic Relevance of Lymph Node Ratio and Number of Resected Nodes After Curative Resection of Ampulla of Vater Carcinoma

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2008 Aug 21
PMID 18712568
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nodal metastasis is considered a major prognostic factor in patients with ampulla of Vater carcinoma (AVC). No study has investigated the significance of the ratio between metastatic and resected/examined lymph nodes (LNR) in patients with AVC.

Methods: Demographic, operative, and pathology data, including number of resected/evaluated nodes and LNR, were collected from patients who underwent pancreaticoduodenectomy with radical intent for invasive AVC from 1990 to 2005. Survival rates and recurrence patterns were evaluated and predictors were identified.

Results: In 90 evaluable patients (51 males, 39 females, median age 62.5 years), 5-year disease-specific survival (DSS) was 61%. The median number of resected/evaluated nodes was 16 (range: 5-47); 50% of the patients had nodal metastases. The 5-year DSS according to LNR was 75%, 49%, 38%, and 0% for LNR = 0, LNR >0 and < or =0.2, LNR >0.2, and < or =0.4, and LNR >0.4 (P = 0.002), respectively. The 5-year DSS was 81% in patients with >16 resected/evaluated nodes compared with 45% in those with < or =16 resected/evaluated nodes (P = 0.001). On multivariate analysis LNR and a number of resected/evaluated nodes >16 were significant predictors of survival; a number of resected/evaluated nodes >16 was also the only independent predictor of recurrence.

Conclusions: After curative resection for AVC, LNR and a cutoff of 16 resected/evaluated nodes are powerful prognostic factors. LNR might represent a major parameter for patient stratification in adjuvant treatment trials.

Citing Articles

The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomy.

Hasegawa S, Wada H, Kubo M, Mukai Y, Mikamori M, Akita H Langenbecks Arch Surg. 2024; 409(1):302.

PMID: 39377937 DOI: 10.1007/s00423-024-03481-y.


Predicting lymph node metastasis using preoperative parameters in patients with T1 ampulla of vater cancer.

Yoon S, Hong S, Jang K, Yoon S, Kim H, Shin S BMC Cancer. 2024; 24(1):935.

PMID: 39090569 PMC: 11293034. DOI: 10.1186/s12885-024-12311-9.


Impact of circumferential resection margin on survival in ampullary cancer: retrospective analysis.

Niessen A, Loos M, Neumuller K, Feisst M, Klaiber U, Cizmic A BJS Open. 2023; 7(6).

PMID: 38155394 PMC: 10754770. DOI: 10.1093/bjsopen/zrad120.


At least 16 lymph nodes are recommended to examine during pancreaticoduodenectomy in ampullary adenocarcinoma.

Zhang X, Sun C, Zhao L, Niu P, Li Z, Fei H Am J Cancer Res. 2023; 13(1):340-351.

PMID: 36777520 PMC: 9906084.


International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma.

Joliat G, Labgaa I, Sulzer J, Vrochides D, Zerbi A, Nappo G Hepatobiliary Surg Nutr. 2022; 11(6):822-833.

PMID: 36523941 PMC: 9745624. DOI: 10.21037/hbsn-21-99.